Bio-Rad
For over six decades, Bio-Rad has served life science research and clinical diagnostics customers worldwide through its global network of operations. Bio-Rad is internationally renowned among academic institutions, pharmaceutical companies and major research institutions for its commitment to quality and customer service.
Latest Bio-Rad Content
Industry Insight
Advancing Antibody Innovation Through Discovery, Customization and Sustainability
In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's custom antibody services team, to learn more about the developments and future directions within antibody innovation.
Product News
Bio-Rad Launches Nuvia wPrime 2A Media for Biomolecule Purification
Scalable weak anion exchange and hydrophobic interaction (AEX-HIC) mixed-mode chromatography resin enables small- to large-scale purification for research and biotherapeutic applications.
Infographic
Mapping Cancer’s Blueprint: Genetics, Metabolism and Targeted Therapies
Download this infographic to learn more about the role of metabolism and genetics in cancer progression, how we can study cancer metabolism and how targeted therapies can be utilized for cancer treatment.
Product News
Geneoscopy Closes $105M in Series C Funding Round To Power Next-Generation of Gastrointestinal Diagnostic Tests
Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease.
Product News
Bio-Rad Extends Range of Foresight Pro Prepacked Chromatography Columns for Biotherapeutic Production
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the launch of Foresight™ Pro 45 cm inner diameter (ID) chromatography columns, designed to support downstream process-scale chromatography applications.
Article
Advances in Biomarker Discovery: From Disease Detection to Cure
This article examines some of the latest advances in biomarker discovery in the fields of cancer and neurodegenerative and infectious diseases and the technologies that are driving these discoveries.
Product
Advertisement
ChemiDoc Go Imaging System
Small Footprint, Big Results
GO Above & Beyond
Introducing the NEW ChemiDoc Go Imaging System
The next generation imager from the ChemiDoc Imaging System line. Effortlessly capture gel and western blot images from your benchtop
GO Above & Beyond
Introducing the NEW ChemiDoc Go Imaging System
The next generation imager from the ChemiDoc Imaging System line. Effortlessly capture gel and western blot images from your benchtop
eBook
Cell and Gene Therapies: Innovations, Challenges and Clinical Breakthroughs
This eBook highlights groundbreaking innovations in cell- and gene-based treatments, delves into strategies to overcome barriers associated with their use and explores real-world clinical breakthroughs.
Infographic
The Evolution of Biopharma Analysis
In this infographic, we journey back through time to trace the evolution of techniques and key regulatory milestones that have shaped biopharma analysis over time.
Product News
Bio-Rad Demonstrates Leadership Position in the Oncology Market at Association for Molecular Pathology 2024
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced updates on its oncology assay portfolio and regulatory milestones, ahead of its presence at the AMP 2024 meeting.
Advertisement
